Fluarix BLA filed
Executive Summary
GlaxoSmithKline announced May 25 the submission of a BLA for its influenza agent Fluarix. In early May, GSK said it plans to provide 10 mil. doses of the product for the 2005-06 flu season and that it had already started the manufacturing ramp-up (1"The Pink Sheet" May 9, 2005, In Brief)...